Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement

BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today closed an upsized priva...

Symbol: XFOR
28 days ago

KP Tissue Releases Second Quarter 2025 Financial Results

Strong profitability with Memphis investment to drive efficiency and support growing U.S. business Strong profitability with Memphis investment to drive efficiency and support growing U.S. business

Symbol: KPTI
28 days ago

Aura Biosciences Reports Second Quarter 2025 Financial Results and Business Highlights

Continued Clinical Program Execution in the Phase 3 CoMpass Trial in Early Choroidal Melanoma and the Phase 1b/2 Trial in Non-Muscle Invasive Bladder Cancer (NMIBC)

Symbol: AURA
28 days ago

Oroco Receives Positive Resolution from Mexico’s Environment Ministry

VANCOUVER, Canada, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO; OTC: ORRCF) (“Oroco” or the “Company”) is pleased to announce that it has received a positive resolution fro...

Symbol: OCO
28 days ago

Immatics Announces Second Quarter 2025 Financial Results and Business Update

Houston, Texas and Tuebingen, Germany, August 13, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision tar...

Symbol: IMTX
28 days ago

Thumzup Media Corporation Announces Strategic Expansion into Digital Asset Mining and Treasury Investments

$50 Million Capital Raise Fuels Growth as U.S. Emerges as Global Digital Asset Hub LOS ANGELES, Aug. 13, 2025 /PRNewswire/ -- Thumzup Media Corporation (Nasdaq: TZUP) ("Thumzup" or the "Company"), ...

Symbol: TZUP
28 days ago

Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results

CAMBRIDGE, Mass., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (A...

Symbol: MRSN
28 days ago

Inotiv, Inc. to Participate in Three Investor Conferences in September 2025

WEST LAFAYETTE, Ind., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytic...

Symbol: NOTV
28 days ago

RADCOM Delivers 19% YoY Revenue Growth and Margin Expansion in the Second Quarter of 2025

Continued Growth and Improved Profitability Reinforce Full-Year Outlook TEL AVIV, Israel, Aug. 13, 2025 /PRNewswire/ -- RADCOM Ltd (Nasdaq: RDCM) announced today its financial results for the secon...

Symbol: RDCM
28 days ago